Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Aug 20145:17 pmRNSNotice of AGM
30th Jun 20146:08 pmRNSTotal Voting Rights
25th Jun 20147:30 amRNSRestoration - Reabold Resources plc
25th Jun 20147:00 amRNSInvesting policy implemented, trading restoration
23rd Jun 20143:27 pmRNSInvestments, Placing, Bank Financing and TVR
13th Jun 20144:57 pmRNSAnnual Financial Report
20th Dec 20137:30 amRNSSuspension of trading and proposed acquisition
20th Dec 20137:30 amRNSSuspension - Reabold Resources plc
30th Sep 20134:28 pmRNSInterim Results for the six months to 30 June 2013
30th Aug 20133:39 pmRNSTotal Voting Rights
16th Aug 20134:35 pmRNSConversion of Loan Notes and TVR
13th Aug 201311:35 amRNSResult of GM and Approval of Rule 9 Waiver
29th Jul 20135:39 pmRNSApproval of Rule 9 waiver and General Meeting
17th Jul 201310:03 amRNSChange of Adviser
28th Jun 201311:41 amRNSFinal Results
12th Jun 20132:22 pmRNSResult of AGM
17th May 20137:00 amRNSPosting of Shareholder Circular
21st Dec 20124:56 pmRNSFinal Results
21st Dec 20124:53 pmRNSRestoration to Trading, etc.
21st Dec 20124:52 pmRNSHalf Yearly Report
19th Dec 201212:52 pmRNSResult of General Meeting etc.
3rd Dec 20125:48 pmRNSNotice of General Meeting
17th Aug 20125:00 pmRNSChange of Adviser
23rd Jul 201212:17 pmRNSAppointment of Administrators
20th Jul 201212:56 pmRNSNotice of Intention to Appoint Administrators
16th Jul 20127:00 amRNSSale of bChannels Ltd and Second2 Ltd
26th Jun 201210:00 amRNSSuspension - Adventis Group Plc
26th Jun 201210:00 amRNSStatement re. Suspension
19th Jun 201210:43 amRNSFurther Update on sale of Technology division
13th Jun 20121:01 pmRNSUpdate on proposed sale of Technology division
10th May 20127:00 amRNSUpdate
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
11th Jan 20127:00 amRNSDisposal
7th Dec 20117:00 amRNSDisposal
28th Sep 20117:00 amRNSHalf Yearly Report
19th Sep 20117:00 amRNSOrderly wind down of Adventis Health
30th Jun 20116:15 pmRNSResult of AGM
23rd Jun 20117:00 amRNSNPA Appeal Upheld
6th Jun 201111:14 amRNSPosting of Annual Report and Notice of AGM
27th May 20117:00 amRNSPreliminary Results - year ended 31 December 2010
12th May 20112:54 pmRNSDirectorate Change
10th May 20117:00 amRNSTrading Update
20th Apr 201112:40 pmRNSDirectorate Change
4th Apr 20119:56 amRNSDirectorate Change
23rd Mar 20112:55 pmRNSNPA - termination of recognition
4th Mar 201111:38 amRNSChange of Registered Office
14th Feb 20117:00 amRNSDirectorate Change
27th Jan 20117:00 amRNSTrading Update
9th Nov 20107:00 amRNSDirectorate Change
15th Sep 20107:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.